BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25955083)

  • 1. Comparison of the proliferation, cytotoxic activity and cytokine secretion function of cascade primed immune cells and cytokine-induced killer cells in vitro.
    Li GX; Zhao SS; Zhang XG; Wang WH; Liu J; Xue KW; Li XY; Guo YX; Wang LH
    Mol Med Rep; 2015 Aug; 12(2):2629-35. PubMed ID: 25955083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activity of cytotoxic dendritic cells cocultured with cytokine-induced killer cells and their effect on acute leukemia cells.
    Cheng XY; Li JL
    Genet Mol Res; 2015 Oct; 14(4):13208-14. PubMed ID: 26535634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of dendritic cells on biological activity of the homologous CIK cells and its anti-leukemia effect in vitro.
    Wei XC; Zhai XH; Han XR; Yang DD; Wang QS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):946-51. PubMed ID: 20723306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Killing activity of co-cultured cytokine-induced killer cells and dendritic cells against multi-drug resistant tumor cell lines].
    Li SJ; Zhang LS; Chai Y; Zhang YF; Zhang YM; Zeng PY; Wu CY
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):733-7. PubMed ID: 18396683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of Achyranthes bidentata polysaccharides stimulated dendritic cells co-cultured with cytokine induced killer cells against SW480 cells].
    Zhou ZD; Xia DJ
    Zhongguo Zhong Yao Za Zhi; 2013 Apr; 38(7):1056-60. PubMed ID: 23847957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK.
    Wang QJ; Wang H; Pan K; Li YQ; Huang LX; Chen SP; He J; Ke ML; Zhao JJ; Li JJ; Sun JC; Liang XT; Ma HQ; Chen YB; Xia JC
    Chin J Cancer; 2010 Jul; 29(7):641-8. PubMed ID: 20591215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thymoglobulin efficiently expands cytokine-induced killer cells in a clinical-grade culture protocol].
    Chen W; Lin D; Jiang Z; Yang Z; Song S; Zhou J; Zhou L; Sun Y; Yu H; Ma D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):681-5, 690. PubMed ID: 25001928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coculture of dendritic cell with cytokine-induced killer results in a significant increase in cytotoxic activity of CIK to tumor cells in vitro and in vivo].
    Ge W; Li CH; Zhang W; Han Q; Deng WM; Chen L; You SG; Zhao CH
    Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):277-80. PubMed ID: 15182535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological activity of DC-CIK cells and its effect against leukemia cells in vitro.
    Wei XC; Zhai XH; Han XR; Yang DD; Zhao WL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1150-3. PubMed ID: 18928615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dendritic cells reduce the number and function of CD4+CD25+ cells in cytokine-induced killer cells].
    Li H; Ren XB; Zhang P; An XM; Liu H; Hao XS
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(44):3134-8. PubMed ID: 16405818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of dendritic cells co-cultured with cytokine induced killer cells on cytotoxicity against drug resistant K562 cells].
    Chen BA; Li M; Sun ZY; Li CP; Gao C; Sun YY; Wang J; Fu Q; Chen J
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):355-8. PubMed ID: 16185482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-15 enhances cytokine induced killer (CIK) cytotoxic potential against epithelial cancer cell lines via an innate pathway.
    Iudicone P; Fioravanti D; Cicchetti E; Zizzari IG; Pandolfi A; Scocchera R; Fazzina R; Pierelli L
    Hum Immunol; 2016 Dec; 77(12):1239-1247. PubMed ID: 27615504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice.
    Jung NC; Lee JH; Choi HJ; Hwang SU; Song JY; Seo HG; Choi J; Jung SY; Han SG; Lim DS
    Immunol Invest; 2016 Aug; 45(6):553-65. PubMed ID: 27410037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Induction of dendritic cells from intra-operative lost blood and their effects on CIK against liver cancer cells in vitro].
    DU Z; Zhao XL; Gao YT; Wu CX; Wang YJ; Zhu ZY; Sun Q; Fang SC
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):759-63. PubMed ID: 19173806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dendritic cells elicit cellular immune response by targeting to capture breast cancer cells].
    Shi YJ; Ren HY; Cen XN; Dong YJ; Ma MX; Zhao YL; Zhu Y; Yu JR
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):107-11. PubMed ID: 18646691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells.
    Niu C; Jin H; Li M; Xu J; Xu D; Hu J; He H; Li W; Cui J
    BMC Immunol; 2015 Oct; 16():61. PubMed ID: 26458364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures.
    Bonanno G; Iudicone P; Mariotti A; Procoli A; Pandolfi A; Fioravanti D; Corallo M; Perillo A; Scambia G; Pierelli L; Rutella S
    J Transl Med; 2010 Dec; 8():129. PubMed ID: 21138560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells infected by Ad-sh-SOCS1 enhance cytokine-induced killer (CIK) cell immunotherapeutic efficacy in cervical cancer models.
    Zheng Y; Hu B; Xie S; Chen X; Hu Y; Chen W; Li S; Hu B
    Cytotherapy; 2017 May; 19(5):617-628. PubMed ID: 28215653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic characterization and anti-tumor effects of cytokine-induced killer cells derived from cord blood.
    Zhang Z; Zhao X; Zhang T; Wang L; Yang L; Huang L; Li F; Liu J; Yue D; Wang F; Li J; Guan F; Xu Y; Zhang B; Zhang Y
    Cytotherapy; 2015 Jan; 17(1):86-97. PubMed ID: 25457278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIK cells from recurrent or refractory AML patients can be efficiently expanded in vitro and used for reduction of leukemic blasts in vivo.
    Wang Y; Bo J; Dai HR; Lu XC; Lv HY; Yang B; Wang T; Han WD
    Exp Hematol; 2013 Mar; 41(3):241-52.e3. PubMed ID: 23123634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.